US Patent Issued to SCIPHER MEDICINE on Jan. 13 for "Method of monitoring anti-TNF therapy in a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier" (Canadian, American Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,525,318, issued on Jan. 13, was assigned to SCIPHER MEDICINE Corp. (Waltham, Mass.).

"Method of monitoring anti-TNF therapy in a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier" was invented by Susan Ghiassian (Coquitlam, Canada), Theodore R. Mellors (Boston), Marc Santolini (Waltham, Mass.), Asher Ameli (Waltham, Mass.), Nancy Schoenbrunner (Charlestown, Mass.), Viatcheslav R. Akmaev (Sudbury, Mass.) and Keith J. Johnson (Wayland, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Presented herein are systems and methods for developing classifiers useful for predicting response to particular treatmen...